Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of October 2021, with a specific reporting date of October 12, 2021. The document serves as a transaction notification regarding dealings in the company's ordinary shares by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) with them.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. It exclusively details specific share transactions.
| Transaction Date | Instrument | Transaction Price | Total Volume (Shares) | Exchange |
|---|---|---|---|---|
| October 7, 2021 | Ordinary Shares (25p each) | £13.9389 | 412 | London Stock Exchange (XLON) |
Note: The total volume of 412 shares represents the aggregate of 12 individual transactions listed in the filing.
Material Changes
No material changes to the company's financial position, operations, or strategy are reported in this filing. The document solely records routine compliance notifications for share acquisitions.
Guidance, Outlook, and Management Commentary
This filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The transactions reported are acquisitions of ordinary shares following the re-investment of dividends paid to shareholders on October 7, 2021, under the Company's Share Reward Plan.
Important Facts for Investor Verification
- Transaction Nature: All reported transactions were acquisitions of shares via dividend re-investment, not open market purchases or sales.
- Participants: Transactions involved senior executives including the CEO (Ms E Walmsley), President of Vaccines & Global Health (Mr R Connor), and other SVPs and officers.
- Share Price: The uniform execution price for all transactions was £13.9389 per share.
- Scope: This filing is a regulatory disclosure of insider trading activity and does not reflect the company's overall financial performance for the period.